Cite
HARVARD Citation
Maini, R. et al. (n.d.). FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx. Annals of the rheumatic diseases. p. A473. [Online].